These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 37735876)

  • 1. Optimal delivery of RNA interference by viral vectors for cancer therapy.
    Wong B; Birtch R; Rezaei R; Jamieson T; Crupi MJF; Diallo JS; Ilkow CS
    Mol Ther; 2023 Nov; 31(11):3127-3145. PubMed ID: 37735876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design of vectors for RNAi delivery system.
    Wang QZ; Lv YH; Diao Y; Xu R
    Curr Pharm Des; 2008; 14(13):1327-40. PubMed ID: 18537656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.
    Anesti AM; Simpson GR; Price T; Pandha HS; Coffin RS
    BMC Cancer; 2010 Sep; 10():486. PubMed ID: 20836854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy.
    Huang PI; Lo WL; Cherng JY; Chien Y; Chiou GY; Chiou SH
    Curr Gene Ther; 2012 Aug; 12(4):275-84. PubMed ID: 22856602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Viral Vectors Any Good for RNAi Antiviral Therapy?
    Lundstrom K
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33092124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular therapeutics of cancer by means of electroporation-based transfer of siRNAs and EBV-based expression vectors.
    Mazda O; Kishida T
    Front Biosci (Elite Ed); 2009 Jun; 1(1):316-31. PubMed ID: 19482649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
    Walther W; Stein U
    Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo application of RNA interference: from functional genomics to therapeutics.
    Lu PY; Xie F; Woodle MC
    Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral gene therapy.
    Mancheño-Corvo P; Martín-Duque P
    Clin Transl Oncol; 2006 Dec; 8(12):858-67. PubMed ID: 17169759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference.
    Bastin D; Aitken AS; Pelin A; Pikor LA; Crupi MJF; Huh MS; Bourgeois-Daigneault MC; Bell JC; Ilkow CS
    J Immunother Cancer; 2018 Jun; 6(1):62. PubMed ID: 29921327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for the quantification of adeno-associated virus vectors for RNA interference applications using quantitative polymerase chain reaction and purified genomic adeno-associated virus DNA as a standard.
    Wagner A; Röhrs V; Kedzierski R; Fechner H; Kurreck J
    Hum Gene Ther Methods; 2013 Dec; 24(6):355-63. PubMed ID: 23987130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.
    Keates AC; Fruehauf J; Xiang S; Li CJ
    Biotechnol Genet Eng Rev; 2008; 25():113-27. PubMed ID: 21412352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi and gene therapy: a mutual attraction.
    Grimm D; Kay MA
    Hematology Am Soc Hematol Educ Program; 2007; ():473-81. PubMed ID: 18024667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer gene therapy using adeno-associated virus vectors.
    Park K; Kim WJ; Cho YH; Lee YI; Lee H; Jeong S; Cho ES; Chang SI; Moon SK; Kang BS; Kim YJ; Cho SH
    Front Biosci; 2008 Jan; 13():2653-9. PubMed ID: 17981740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference: a potent tool for gene-specific therapeutics.
    Ichim TE; Li M; Qian H; Popov IA; Rycerz K; Zheng X; White D; Zhong R; Min WP
    Am J Transplant; 2004 Aug; 4(8):1227-36. PubMed ID: 15268723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of AAV Vectors for Delivery of RNAi.
    Borel F; Mueller C
    Methods Mol Biol; 2019; 1950():3-18. PubMed ID: 30783965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.
    Herrera-Carrillo E; Liu YP; Berkhout B
    Hum Gene Ther Methods; 2017 Aug; 28(4):177-190. PubMed ID: 28712309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral Vectors Applied for RNAi-Based Antiviral Therapy.
    Lundstrom K
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32842491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.